The drug regulatory body of India, DCGI is waiting for the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) approval to AstraZeneca & Oxford’s COVID19 Vaccine, before giving a nod for Emergency Use Authorisation to its Indian counterpart developed by Serum Institute of India (SII) . It’s expected for British- Sweden giant drugmaker AstraZeneca in the UK to get authorization at any time, Sources to The Medically Speaking team
Breaking – Drug regulatory of India may give clearance to AstraZeneca’s COVID-19 VACCINE after MHRA
previous post